title: Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.
abstract: BACKGROUND
  One of the main determinants of public immunization success is health professionals' support and recommendations. Little is known about the physicians' level of support and intentions regarding A(H1N1) pandemic influenza vaccination. The aim of this survey was to document Canadian family physicians' and paediatricians' knowledge, attitudes and practices (KAP) as well as their intentions regarding A(H1N1) pandemic influenza vaccines right before the beginning of the largest immunization campaign in Canadian history.
  
  
  RESULTS
  A self-administered, anonymous, mail-based questionnaire was sent to a random sample of family physicians and to all paediatricians practicing in Canada. All 921 questionnaires received by October 29 2009 were included in the analysis. Between 72% and 92% of respondents agreed with the statements regarding vaccine safety, effectiveness and acceptability. More than 75% of respondents intended to recommend the A(H1N1) pandemic influenza vaccine to their patients and to get vaccinated themselves. The most significant factors associated with the intention to recommend A(H1N1) pandemic vaccines were physicians' intention to be vaccinated against influenza themselves and the perceived acceptability of the vaccine by the vaccinators.
  
  
  CONCLUSIONS
  Most Canadian family physicians and paediatricians surveyed were supportive of the A(H1N1) pandemic influenza vaccination before its implementation and large media coverage.
authors.affiliation: Centre de recherche du CHUL-CHUQ, Centre Hospitalier de l'Université Laval, Québec, Canada. eve.dube@ssss.gouv.qc.ca.
authors.forename: Eve
authors.initials: E
authors.lastname: Dubé
authors.forename: Vladimir
authors.initials: V
authors.lastname: Gilca
authors.forename: Chantal
authors.initials: C
authors.lastname: Sauvageau
authors.forename: Nicole
authors.initials: N
authors.lastname: Boulianne
authors.forename: François D
authors.initials: FD
authors.lastname: Boucher
authors.forename: Julie A
authors.initials: JA
authors.lastname: Bettinger
authors.forename: Shelly
authors.initials: S
authors.lastname: McNeil
authors.forename: Ian
authors.initials: I
authors.lastname: Gemmill
authors.forename: France
authors.initials: F
authors.lastname: Lavoie
authors.forename: Manale
authors.initials: M
authors.lastname: Ouakki
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/201-9
references.pmid: 16950008
references.citation: Euro Surveill. 2009 Oct 15;14(41):19356
references.pmid: 19883541
references.citation: Infect Dis Obstet Gynecol. 2004 Sep-Dec;12(3-4):127-33
references.pmid: 15763912
references.citation: Med J Aust. 2009 Sep 7;191(5):267-9
references.pmid: 19740048
references.citation: Int J Nurs Stud. 2009 Sep;46(9):1219-35
references.pmid: 19349047
references.citation: Vaccine. 2005 Mar 31;23(19):2470-6
references.pmid: 15752833
references.citation: Prev Med. 2007 Aug-Sep;45(2-3):107-14
references.pmid: 17628649
references.citation: J R Soc Interface. 2007 Jun 22;4(14):505-21
references.pmid: 17251132
references.citation: Vaccine. 2009 Sep 25;27(42):5732-4
references.pmid: 19679219
references.citation: BMJ. 2009 Aug 25;339:b3391
references.pmid: 19706937
references.citation: J Immune Based Ther Vaccines. 2003 Nov 5;1(1):3
references.pmid: 14613575
references.citation: Vaccine. 2007 Nov 7;25(45):7841-7
references.pmid: 17923173
references.citation: Vaccine. 2008 Aug 5;26(33):4204-9
references.pmid: 18582998
references.citation: JAMA. 2001 Apr 11;285(14):1874-9
references.pmid: 11308401
references.citation: BMC Health Serv Res. 2009 Feb 13;9:30
references.pmid: 19216792
references.citation: Pediatrics. 1993 Apr;91(4):699-702
references.pmid: 8385309
references.citation: BMJ. 2009 Oct 27;339:b4164
references.pmid: 19861377
references.citation: Vaccine. 2009 Feb 18;27(8):1242-7
references.pmid: 19114078
references.citation: CMAJ. 2009 Nov 10;181(10):673-80
references.pmid: 19825923